VAN DER MOST Robbert

Robbert van der Most, PhD, is an immunologist and vaccine R&D specialist with more than 16 years of experience in vaccine development. After obtaining his PhD in molecular virology from Leiden University, he pursued postdoctoral research in the United States, Australia and the Netherlands. He subsequently joined GSK Vaccines, where he led translational science activities across several vaccine programmes, before joining CEPI and then BioNTech as Vice-President of Translational Science for infectious diseases. In 2024, he founded VaxxCellence, an independent consultancy specialising in vaccine development and translational immunology. He has authored more than 100 peer-reviewed publications, with research spanning antiviral and vaccine immunity, translational immunology and, more recently, the links between infection, vaccination and dementia risk.

Abstract: « Infection, vaccination and risk of dementia: a proposed immunological model »